Informations générales (source: ClinicalTrials.gov)
PLANning Your Every Day Life I Virtual REality : a Study Schizophrenia. Mathurin Serious Game (PlaniRev)
Interventional
N/A
Centre Hospitalier St Anne (Voir sur ClinicalTrials)
octobre 2018
août 2024
17 août 2024
Patients with schizophrenia , who visit frenquently day-care or day-care activities
clinics, often experience difficulties of daily living and cognitive deficits. Living
independently is a key for recovery. Cognitive remediation is a therapy which reduces
deficit and improves daily living. Nowadays no program exists targeting neurocognitive
functions in virtual reality which could mimic everyday life in a virtual town.
Hypotheses :
- Persons with schizophrenia experience difficulties in daily living and disabilities
to plan in everyday life. PLANI-REV program, a serious game with a navigation in a
virtual town, in a 15 weekly group sessions could reduce these difficulties compared
to the initial assessment. This improvement could be maintained 6 months after the
end of the program.
- PLANI-REV could also improve prospective memory, attention, working memory, and
visuospatial organization.
- PLANI-REV could induce a clinical improvement, as well as better perception of
self-efficiency, self esteem, quality of life, and conversation skills.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Centre Hospitalier Guillaume Régnier - 35703 - Rennes - France | David LEVOYER, MD | Contact (sur clinicalTrials) | |||
| Centre Hospitalier Sainte Anne - 75674 - Paris - France | Isabelle AMADO, MD | Contact (sur clinicalTrials) | |||
| Hopital les Murets - 94510 - La Queue-en-Brie - France | Olivier QUENZER, MD | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Hospitalier DURANT - Etampes - France | François PETITJEAN, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Age between 18 and 50 years old.
- Diagnostic of schizophrenia or schizoaffective disorder (DSM V), attested by the
MINI structured interview (Shehan et al. 1998)
- Who visit for months or year, weekly or several times per week, a day care, or
therapeutic activity units outpatients clinics and nursing homes
- French Mother tongue
- Consent of the legal representative caregiver for the patients under representative
law (tutelle in French).
- Clinical Stability - Therapeutic stability for at least one month.
- National healthcare assurance
- Age between 18 and 50 years old.
- Diagnostic of schizophrenia or schizoaffective disorder (DSM V), attested by the
MINI structured interview (Shehan et al. 1998)
- Who visit for months or year, weekly or several times per week, a day care, or
therapeutic activity units outpatients clinics and nursing homes
- French Mother tongue
- Consent of the legal representative caregiver for the patients under representative
law (tutelle in French).
- Clinical Stability - Therapeutic stability for at least one month.
- National healthcare assurance
- Central Neurological or non stabilized somatic diseases.
- Treatments for somatic disease with putative psychotropic effect.
- Electroconvulsive therapy in the last six months
- Illetrism
- IQ< 70 established with the f-NART.
- Substance misuse or dependence (except Nicotine) or toxic for more than 5 years.